Pharmacy & Pharmacology,
Год журнала:
2023,
Номер
11(2), С. 137 - 148
Опубликована: Авг. 8, 2023
The
aim
of
the
work
was
to
study
сytokine
response
characteristics
in
group
persons
contacted
by
a
novel
coronavirus
infection
depending
on
development
disease
over
next
14
days.
Herewith,
for
immunocorrection
with
preparation
based
RNA
double-stranded
sodium
salt
(RADAMIN®VIRO)
causing
secondary
reduction
risk
COVID-19
analyzed
group,
potential
targets
had
been
selected.
Materials
and
methods.
A
double-blind,
placebo-controlled
drug
therapeutic
effects
conducted
patients
who
contact
having
confirmed
diagnosis
COVID-19.
method
enzyme
immunoassay
dynamics
used
determine
content
interferons
alpha
beta
(IFNα
IFNβ,
respectively),
interleukin-1β
-10
(IL1β
IL-10,
respectively)
blood
serum
saliva
persons,
retrospective
assessment
changes
administration
or
placebo,
as
well
Results.
In
course
presented
study,
it
demonstrated
that
established
IFNα
(less
than
28
pg/ml)
IFNβ
12
1
st
–2
nd
days
is
predictor
an
increased
developing
increase
degree
these
immunoregulatory
peptides
interval
2–3
important:
allows
leveling
negative
prognosis
250%
more.
lowest
rates
(
p
<0.001)
INFα
days,
less
21%
3
rd
day,
were
observed
waist
circumference
more
80/94
cm
(women/men).
incidence
this
higher
amounted
85%
(16
out
20
people).
role
IL-1β
IL-10
relation
start
infectious
process
not
revealed.
made
possible
correct
interferon
form
reduce
comparison
placebo
group.
Conclusion.
Differences
regulation
upon
SARS-CoV-2
lower
INF
α
β
levels,
slightly
pronounced
growth
first
influenced
RADAMIN®VIRO
can
be
recommended
means
post-exposure
prophylaxis
both
medical
institutions
caregivers
/
contacts
patients.
Journal of Epidemiology and Global Health,
Год журнала:
2024,
Номер
unknown
Опубликована: Окт. 8, 2024
Abstract
Background
As
the
impact
of
SARS-CoV-2
pandemic
extends
into
2023
and
beyond,
treatment
outcomes
infected
patients
continues
to
evolve.
Unlike
earlier
in
there
are
now
further
infectious
disease
pressures
placed
on
hospitals,
which
influence
patient
care
triage
decisions.
Methods
The
manuscript
uses
individual
records
linked
with
associated
hospital
management
information
system
pressure
characteristics
attribute
COVID-19
hospitalisation
fatality
risks
(HFR)
using
generalised
additive
mixed
effects
models.
Results
Between
01
September
2022
09
October
2023,
risk
England
was
estimated
as
12.71%
(95%
confidence
interval
(CI)
12.53%,
12.88%).
Staff
absences
had
an
adjusted
odds
ratio
1.038
CI
1.017,
1.060)
HFR
when
accounting
for
characteristics.
Interpretation
This
observational
research
presents
evidence
that
a
range
local
can
have
meaningful
death
from
once
hospitalised
should
be
accounted
reporting
estimates.
We
show
both
case
mix
estimates
outcomes.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(23), С. 12641 - 12641
Опубликована: Ноя. 25, 2024
The
variants
of
concern
(VOCs)
SARS-CoV-2
have
exhibited
different
phenotypic
characteristics
in
clinical
settings
which
are
yet
to
be
fully
explored.
This
study
aimed
characterize
the
viral
replication
features
major
VOCs
and
their
association
with
pathogenicity.
Alpha,
Delta,
Omicron
isolated
from
COVID-19
patients
Japan
were
propagated
VeroE6/TMPRSS2
cells.
pathological
evaluated
by
laser
electron
microscopy
at
time
points.
results
revealed
that
Delta
variant
dominantly
infected
cells
formed
increased
syncytia
compared
Alpha
variants.
Relatively
large
numbers
virions
immunoreactivities
N-protein
detected
endoplasmic
reticulum
intracellular
vesicles
Delta-infected
Interestingly,
nucleus
cells,
while
such
properties
not
observed
case
In
addition,
early
nuclear
membrane
damage
followed
severe
cellular
was
prominent
A
unique
mutation
(G215C)
is
thought
associated
cell
damage.
conclusion,
this
highlights
distinct
replicative
pathogenic
variants,
shedding
light
on
potential
mechanisms
underlying
its
Applied Economics,
Год журнала:
2023,
Номер
56(34), С. 4100 - 4113
Опубликована: Май 10, 2023
We
evaluate
the
effects
of
vaccines
in
evolution
epidemic
Spain
during
2021.
To
this
end,
we
estimate
effect
vaccination
terms
reducing
infections,
hospitalizations,
ICU
admissions,
and
deaths.
also
compare
health
impact
COVID-19
with
that
caused
by
recent
influenza
seasons,
a
scenario
where
all
population
had
been
vaccinated.
The
positive
on
indicators
has
extraordinary.
non-availability
would
have
increased
deaths
571%
compared
to
observed
Moreover,
relative
benefit
increases
severity
indicator:
greater
for
less
infections
hospitalizations.
Under
assumption
entire
vaccinated
vaccine
from
first
week
April,
disease
hospitalizations
2021
above
low
activity
flu
season,
but
line
moderate/high
season.
Asia-pacific Journal of Convergent Research Interchange,
Год журнала:
2023,
Номер
9(7), С. 287 - 297
Опубликована: Июль 31, 2023
Several
studies
have
examined
the
clinical
efficacy
of
COVID-19
vaccine,
but
there
is
still
a
lack
research
on
worldwide
policy
effects
vaccination
efforts.Understanding
global
impact
campaigns
in
managing
spread
essential.This
study
explores
influence
vaccine
coverage
occurrence
and
death
rates
before
after
emergence
Omicron
variant.Data
from
119
countries
Our
World
Data
platform
was
examined,
with
daily
cases
per
million
people
100
as
some
variables
analyzed.In
pre-Omicron
era,
vaccinated
hundred
had
negative
association
deaths
non-lagged
model,
while
14
days-lagged
models
significantly
positive
association.For
fully
hundred,
both
association.Daily
tests
thousand
were
positively
associated
dayslagged
for
deaths.In
post-Omicron
models,
deaths.Daily
statistically
associations
deaths,
except
deaths.Vaccination
has
been
more
preventing
COVID-19,
particularly
reduced
mortality.Moreover,
new
dose
affected
incidence
mortality.
Pharmacy & Pharmacology,
Год журнала:
2023,
Номер
11(2), С. 137 - 148
Опубликована: Авг. 8, 2023
The
aim
of
the
work
was
to
study
сytokine
response
characteristics
in
group
persons
contacted
by
a
novel
coronavirus
infection
depending
on
development
disease
over
next
14
days.
Herewith,
for
immunocorrection
with
preparation
based
RNA
double-stranded
sodium
salt
(RADAMIN®VIRO)
causing
secondary
reduction
risk
COVID-19
analyzed
group,
potential
targets
had
been
selected.
Materials
and
methods.
A
double-blind,
placebo-controlled
drug
therapeutic
effects
conducted
patients
who
contact
having
confirmed
diagnosis
COVID-19.
method
enzyme
immunoassay
dynamics
used
determine
content
interferons
alpha
beta
(IFNα
IFNβ,
respectively),
interleukin-1β
-10
(IL1β
IL-10,
respectively)
blood
serum
saliva
persons,
retrospective
assessment
changes
administration
or
placebo,
as
well
Results.
In
course
presented
study,
it
demonstrated
that
established
IFNα
(less
than
28
pg/ml)
IFNβ
12
1
st
–2
nd
days
is
predictor
an
increased
developing
increase
degree
these
immunoregulatory
peptides
interval
2–3
important:
allows
leveling
negative
prognosis
250%
more.
lowest
rates
(
p
<0.001)
INFα
days,
less
21%
3
rd
day,
were
observed
waist
circumference
more
80/94
cm
(women/men).
incidence
this
higher
amounted
85%
(16
out
20
people).
role
IL-1β
IL-10
relation
start
infectious
process
not
revealed.
made
possible
correct
interferon
form
reduce
comparison
placebo
group.
Conclusion.
Differences
regulation
upon
SARS-CoV-2
lower
INF
α
β
levels,
slightly
pronounced
growth
first
influenced
RADAMIN®VIRO
can
be
recommended
means
post-exposure
prophylaxis
both
medical
institutions
caregivers
/
contacts
patients.